Clinical Trials

Any further development efforts for either of our product candidates is dependent on our ability to raise additional capital.

Androxal®

If you are interested in participating, and want to know if you may qualify, please visit www.HelpMyLowT.com or call 855-TEST-MY-T or Repros at 800-895-6554 ext 3403.


Current recruiting locations:


Alabama
Birmingham
Mobile

Florida
Jacksonville

Illinois
Evanston

Kentucky
Lexington

North Carolina
Raleigh
New York
Albany
Garden City
New York
Rochester

Ohio
Beachwood

Oregon
Medford

Rhode Island
Warwick
South Carolina
Myrtle Beach, SC

Tennessee
Nashville

Texas
Houston
Webster

Utah
Riverton

Virginia
Norfolk

Ongoing Studies

Androxal® - Head to Head Study of Androxal® Versus the Leading Topical Testosterone Gel (ZA-304) (Currently Recruiting)


Androxal® - Head to Head Study of Androxal® Versus the Leading Topical Testosterone Gel (ZA-305) (Currently Recruiting)


Androxal® - Pharmacokinetic and Safety Profile of Androxal in Male Subjects with Impaired Renal Function (ZA-104) (Currently Recruiting)

Purpose: To determine and compare the pharmacokinetics (PK) and safety profile of a single dose of 25 mg Androxal in overweight male subjects with various stages of renal impairment and in volunteers with normal renal function.


Androxal® - An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism (ZA-301ext) (Recruitment Closed)

Purpose: To evaluate the safety on continued treatment with Androxal in subjects who completed either ZA-301 or ZA-302.


Androxal® - Assess the Effects on Bone Mineral Density (ZA-303) (Recruitment Closed)

Purpose: To determine the effects of 12 months of treatment with Androxal on Bone Mineral Density in men with secondary Hypogonadism.



Proellex®

If you are interested in participating, and want to know if you may qualify, please call 800-895-6554 ext 3401.


Current recruiting locations:


Arkansas
Little Rock

Florida
Clearwater
Margate
South Carolina
Summerville

Texas
Houston
Utah
Riverton
Salt Lake City

Ongoing Studies

Proellex® - Treatment of Pre-Menopausal Women with Confirmed, Symptomatic Endometriosis (ZPE-202) (Currently recruiting)

Purpose: To determine the safety and efficacy of two doses of Proellex in premenopausal women with pelvic pain in endometriosis confirmed within the last seven years and using prescription analgesics for symptomatic pain.

Proellex® - Extension Study for Premenopausal Women with Uterine Fibroids Who Have Completed ZPV-200 (ZPV-200ext) (Recruitment Closed)

Purpose: To further determine the safety and efficacy of Proellex in premenopausal women with uterine fibroids who have previously completed study ZPV-200.


2408 Timberloch Place, B-7
The Woodlands, Texas 77380
281-719-3400
281-719-3446 fax